GlassScriptPhysician profile
William Horsley
NPI 1841341369
$16,388.98
in general payments reported to CMS, 2019-2025
28 companies · $873 in 2025
The $873 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,467 · 2020: $450 · 2021: $4,633 · 2022: $1,851 · 2023: $1,427 · 2024: $1,688 · 2025: $873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,850 · Education: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,849.96 |
| Education | $137.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $4,961.11 | 2019-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Medtronic, INC. | $4,660.09 | 2021-2024 | Endurant Iis, Signia |
| Angiodynamics, INC. | $1,545.30 | 2021-2023 | Auryon Laser System 100-120 Vac |
| W. L. Gore & Associates, INC. | $1,144.99 | 2019-2024 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Edwards Lifesciences Corporation | $655.45 | 2019-2025 | Konect Resilia, Mitris Resilia Mitral Valve |
| Abiomed | $632.36 | 2019-2025 | Impella |
| Covidien LP | $437.54 | 2019 | |
| Cardiovascular Systems INC. | $401.02 | 2019-2022 | |
| Medtronic Vascular, INC. | $363.80 | 2019-2020 | |
| Stryker Corporation | $357.22 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $311.87 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $126.18 | 2019-2022 | |
| Endologix LLC | $119.20 | 2019 | |
| Ethicon US, LLC | $117.62 | 2019-2025 | Echelon Flex, Harmonic, Echelon Endopath |
| Davol INC. | $103.59 | 2024 | Phasix Mesh |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $81.47 | 2020 | |
| Karl Storz Endoscopy-America | $69.36 | 2022 | |
| Acera Surgical, INC. | $44.09 | 2025 | Restrata Wound Matrix |
| Penumbra, INC. | $43.95 | 2022 | |
| Boston Scientific Corporation | $39.71 | 2023 | Eluvia |
| Smith+Nephew, INC. | $32.05 | 2019-2024 | Pico 7, Renasys Touch, Renasys Go V2 Home |
| Merck Sharp & Dohme LLC | $27.40 | 2025 | Keytruda |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.44 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.83 | 2022 | |
| Inspiremd LTD | $16.26 | 2025 | Cguard Prime Carotid Stent System |
| Lsi Solutions INC | $16.16 | 2025 | Cor-Knot |
| Getinge USA Sales, LLC | $16.00 | 2022 | |
| Lemaitre Vascular, INC. | $14.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Horsley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.